corevalve evolut r (CoreValve Inc)
90
Structured Review
CoreValve Inc
corevalve evolut r
Corevalve Evolut R, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/corevalve+evolut+r/corevalve+prosthesis/pm40643039-58-14-14
Average 90 stars, based on 1 article reviews
Corevalve Evolut R, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/corevalve+evolut+r/corevalve+prosthesis/pm40643039-58-14-14
Average 90 stars, based on 1 article reviews
corevalve evolut r - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison. Article Snippet: The main findings of the study are: (1) compared to the SAPIEN-3/3 Ultra, mild PVL was more frequently found in the Article Title: Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison Article Snippet: Our study is in line with these previously published data demonstrating a higher rate of PVL for the Article Title: Late arrhythmic burden in patients with left bundle branch block after TAVR with the Evolut valve. Article Snippet: In subsequent clinical trials, use of CoreValve, Evolut R, or Evolut 17 PRO in low-risk patients resulted in Article Title: Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison Article Snippet: The Article Title: Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison. Article Snippet: Notably, compared with the Article Title: TAVI Success Is More Than Just the Valve: CT-Derived Sarcopenia as a Major Determinant of Long-Term Survival. Article Snippet: All patients underwent transfemoral TAVI with second- or third- generation valve systems, namely, the Selection:Article Title: Transapical vs. Transaxillary Access in Transcatheter Aortic Valve Implantation: Comparative Mortality and Long-Term Outcomes Using Inverse Probability of Treatment Weighting Analysis. Article Snippet: .. Valve prosthesis selection was determined by the heart team or operator, with Control:Article Title: Valve Under-Expansion and Clinical Outcomes with ACURATE neo2: Findings from the ACURATE IDE Trial. Article Snippet: Objective: Assess the impact of ACURATE neo2 valve expansion on clinical outcomes in the ACURATE IDE trial.. Background: In the ACURATE IDE randomized controlled trial, ACURATE neo2 failed to demonstrate noninferiority to commercially available balloon-expandable (SAPIEN 3/3 Ultra) and self-expanding (Evolut R/PRO/PRO+/FX) valves for the primary endpoint of all-cause mortality, stroke, or rehospitalization at 1 year.. A retrospective investigation was undertaken to evaluate potential factors contributing to these outcomes. |